FDA letter monthly archive

FDA Letters Issued in January 2012

Name: FDA Letters Issued in January 2012
Creator: Assyro AI
License: https://www.usa.gov/government-works

Browse FDA application-action, complete response, and warning letters issued in January 2012. Each result links to a structured letter page with source-document access, metadata, and regulatory intelligence summaries.

CRLComplete Response Letter
Complete Response Letter Bristol-Myers Squibb (Jan 17, 2012)
FDA's complete response letter contains source-text evidence related to Safety and adverse events, Clinical efficacy and substantial evidence, Labeling, packaging, and proprietary name. Theme counts identify where the letter discusses a topic; they do not replace review of the exact redacted letter.
IssuedJan 17, 2012
US FDA• FARXIGA

Complete Response Letter Bristol-Myers Squibb (Jan 17, 2012)